Rankings
▼
Calendar
AMRN FY 2014 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$338M
FY 2014 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$54M
+105.7% YoY
Gross Profit
$34M
62.2% margin
Operating Income
-$96M
-177.0% margin
Net Income
-$56M
-104.0% margin
EPS (Diluted)
$-7.20
Cash Flow
Operating Cash Flow
-$72M
Free Cash Flow
-$72M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$171M
Total Liabilities
$260M
Stockholders' Equity
-$88M
Cash & Equivalents
$120M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$54M
$26M
+105.7%
Gross Profit
$34M
$14M
+133.5%
Operating Income
-$96M
-$182M
+47.3%
Net Income
-$56M
-$166M
+66.1%
← FY 2013
All Quarters
FY 2015 →